Overview

Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The present trial investigates the long-term safety, tolerability and efficacy of bosentan in patients with inoperable CTEPH.
Phase:
Phase 3
Details
Lead Sponsor:
Actelion
Treatments:
Bosentan